Origio A/S, A Coopersurgical Company
DenmarkFDA applicant, unverified
- Devices
- 1
What Origio A/S, A Coopersurgical Company makes
Origio A/S manufactures Synvitro Hyadase, an enzyme-based medical device designed for tissue preparation and processing in laboratory settings, aiding in histological analysis.
The device is classified as Class II under FDA regulations and is listed via the 510(k) pathway. The company is based in the United States.
Catalogue
Synvitro Hyadase Ref K200680
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Origio A/S, A Coopersurgical Company have in the registry?
The registry currently lists 1 device for Origio A/S, A Coopersurgical Company. Devices recorded under merged duplicate company entries are counted once.
Which registries list Origio A/S, A Coopersurgical Company's devices?
Among its 1 most recently registered device, Origio A/S, A Coopersurgical Company has devices listed in FDA 510(k) (1 device).
What risk classes do Origio A/S, A Coopersurgical Company's devices fall under?
Among its 1 most recently registered device, the classes recorded for Origio A/S, A Coopersurgical Company's devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Origio A/S, A Coopersurgical Company in the registry?
The most recently registered devices listed for Origio A/S, A Coopersurgical Company include Synvitro Hyadase.